As 2025 begins, Milei's administration faces two pivotal challenges that will determine the sustainability of his stabilization program. The upcoming mid-term elections in October will be a test ...

To mark upcoming Rare Disease Day, pharmaphorum asked a panel of experts to give their thoughts on the opportunities and challenges facing developers of rare disease therapies in 2024. The panel ...